{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:34:46Z","timestamp":1790663686927,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009060","name":"Sidaction","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100009060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Achieving durable viral remission without antiretroviral therapy (ART) remains a central challenge in HIV-1 cure research. Using a pathogenic SIV model in male cynomolgus macaques, we investigated mucosal and systemic immune features associated with post-treatment control (PTC). Chronic SIV infection disrupts intestinal macrophage homeostasis, skewing the compartment toward a CX3CR1\n                    <jats:sup>low<\/jats:sup>\n                    inflammatory phenotype marked by increased expression of costimulatory and homing markers. This polarization is associated with mucosal CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell depletion, elevated neutrophil activation, and systemic cytokine induction. Non-controllers exhibit a similar inflammatory profile. In contrast, PTCs maintain CX3CR1\n                    <jats:sup>high<\/jats:sup>\n                    macrophages, preserve regulatory CD4\u2009+\u2009T cells, and exhibit attenuated mucosal and systemic immune activation, resembling uninfected animals. CX3CR1\n                    <jats:sup>high<\/jats:sup>\n                    macrophage abundance inversely correlates with viral burden, T cell activation, and pro-inflammatory cytokines, suggesting a potential role in post-treatment control. These findings identify CX3CR1-expressing intestinal macrophages as a potential biomarker of mucosal immune regulation and highlight their relevance as targets in HIV cure strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-69848-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:15:27Z","timestamp":1771913727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques"],"prefix":"10.1038","volume":"17","author":[{"given":"St\u00e9phane","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keltouma","family":"Benmeziane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-3914","authenticated-orcid":false,"given":"Delphine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3252-4789","authenticated-orcid":false,"given":"Nastasia","family":"Dimant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Leonec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-9277","authenticated-orcid":false,"given":"Laetitia","family":"Bossevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-0110","authenticated-orcid":false,"given":"Julien","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-0201","authenticated-orcid":false,"given":"Adeline","family":"M\u00e9lard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6387-8481","authenticated-orcid":false,"given":"Francis","family":"Relouzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-2990","authenticated-orcid":false,"given":"Ve\u0301ronique","family":"Avettand-Feno\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-6313","authenticated-orcid":false,"given":"Nathalie","family":"Dereuddre-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-7536","authenticated-orcid":false,"given":"Asier","family":"Sa\u0301ez-Cirio\u0301n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4928-4484","authenticated-orcid":false,"given":"Roger","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8468-0263","authenticated-orcid":false,"given":"Mariangela","family":"Cavarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"69848_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/QAD.0000000000000987","volume":"30","author":"R Calin","year":"2016","unstructured":"Calin, R. et al. Treatment Interruption in Chronically HIV-Infected Patients with an Ultralow HIV Reservoir. AIDS 30, 761\u2013769 (2016).","journal-title":"AIDS"},{"key":"69848_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/cid\/ciab541","volume":"74","author":"JZ Li","year":"2022","unstructured":"Li, J. Z. et al. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Clin. Infect. Dis. 74, 865\u2013870 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"69848_CR3","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li, J. Z. et al. The Size of the Expressed HIV Reservoir Predicts Timing of Viral Rebound after Treatment Interruption. AIDS 30, 343\u2013353 (2016).","journal-title":"AIDS"},{"key":"69848_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","volume":"24","author":"DJ Colby","year":"2018","unstructured":"Colby, D. J. et al. Rapid HIV RNA Rebound after Antiretroviral Treatment Interruption in Persons Durably Suppressed in Fiebig i Acute HIV Infection. Brief. -Commun. Nat. Med 24, 923\u2013926 (2018).","journal-title":"Brief. -Commun. Nat. Med"},{"key":"69848_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.medj.2022.06.009","volume":"3","author":"T Mdluli","year":"2022","unstructured":"Mdluli, T. et al. Acute HIV-1 Infection Viremia Associate with Rebound upon Treatment Interruption. Med 3, 622\u2013635.e3 (2022).","journal-title":"Med"},{"key":"69848_CR6","doi-asserted-by":"publisher","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).","journal-title":"PLoS Pathog."},{"key":"69848_CR7","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/infdis\/jiy479","volume":"218","author":"G Namazi","year":"2018","unstructured":"Namazi, G. et al. The Control of HIV after Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified from 14 Clinical Studies. J. Infect. Dis. 218, 1954\u20131963 (2018).","journal-title":"J. Infect. Dis."},{"key":"69848_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJM199905273402114","volume":"340","author":"J Lisziewicz","year":"1999","unstructured":"Lisziewicz, J. et al. Control of HIV despite the Discontinuation of Antiretroviral Therapy. N. Engl. J. Med. 340, 1683\u20131683 (1999).","journal-title":"N. Engl. J. Med."},{"key":"69848_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1097\/QAD.0b013e32833b61ba","volume":"24","author":"L Hocqueloux","year":"2010","unstructured":"Hocqueloux, L. et al. Long-Term Immunovirologic Control Following Antiretroviral Therapy Interruption in Patients Treated at the Time of Primary HIV-1 Infection. AIDS 24, 1598\u20131601 (2010).","journal-title":"AIDS"},{"key":"69848_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3851\/IMP2273","volume":"17","author":"C Goujard","year":"2012","unstructured":"Goujard, C. et al. HIV-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy. Antivir. Ther. 17, 1001\u20131009 (2012).","journal-title":"Antivir. Ther."},{"key":"69848_CR11","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/QAD.0000000000000734","volume":"29","author":"L Assoumou","year":"2015","unstructured":"Assoumou, L. et al. A Low HIV-DNA Level in Peripheral Blood Mononuclear Cells at Antiretroviral Treatment Interruption Predicts a Higher Probability of Maintaining Viral Control. AIDS 29, 2003\u20132007 (2015).","journal-title":"AIDS"},{"key":"69848_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/nature03501","volume":"434","author":"JJ Mattapallil","year":"2005","unstructured":"Mattapallil, J. J. et al. Massive infection and loss of memory CD4\u2009+\u2009T cells in multiple tissues during acute SIV infection. Nature 434, 1093\u20131097 (2005).","journal-title":"Nature"},{"key":"69848_CR13","doi-asserted-by":"publisher","first-page":"e1001052","DOI":"10.1371\/journal.ppat.1001052","volume":"6","author":"JD Estes","year":"2010","unstructured":"Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052 (2010).","journal-title":"PLoS Pathog."},{"key":"69848_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1126\/science.280.5362.427","volume":"280","author":"RS Veazey","year":"1998","unstructured":"Veazey, R. S. et al. Gastrointestinal tract as a major site of CD4\u2009+\u2009T cell depletion and viral replication in SIV infection. Science 280, 427\u2013431 (1998). (1979).","journal-title":"Science"},{"key":"69848_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley, J. M. et al. CD4\u2009+\u2009T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749\u2013759 (2004).","journal-title":"J. Exp. Med."},{"key":"69848_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med 12, 1365\u20131371 (2006).","journal-title":"Nat. Med"},{"key":"69848_CR17","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","volume":"77","author":"M Guadalupe","year":"2003","unstructured":"Guadalupe, M. et al. Severe CD4\u2009+\u2009T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708\u201311717 (2003).","journal-title":"J. Virol."},{"key":"69848_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","volume":"210","author":"PW Hunt","year":"2014","unstructured":"Hunt, P. W. et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210, 1228\u20131238 (2014).","journal-title":"J. Infect. Dis."},{"key":"69848_CR19","doi-asserted-by":"publisher","first-page":"e97171","DOI":"10.1371\/journal.pone.0097171","volume":"9","author":"AK Steele","year":"2014","unstructured":"Steele, A. K. et al. Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature. PLoS One 9, e97171 (2014).","journal-title":"PLoS One"},{"key":"69848_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/cid\/ciw683","volume":"64","author":"I Sereti","year":"2017","unstructured":"Sereti, I. et al. Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin. Infect. Dis. 64, 124\u2013131 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"69848_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667\u2013685 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"69848_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12192","volume":"260","author":"CC Bain","year":"2014","unstructured":"Bain, C. C. & Mowat, A. M. Macrophages in intestinal homeostasis and inflammation. Immunol. Rev. 260, 102\u2013117 (2014).","journal-title":"Immunol. Rev."},{"key":"69848_CR23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/mi.2017.22","volume":"10","author":"T Joeris","year":"2017","unstructured":"Joeris, T., M\u00fcller-Luda, K., Agace, W. W. & Mowat, A. M. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol. 10, 845\u2013864 (2017).","journal-title":"Mucosal Immunol."},{"key":"69848_CR24","doi-asserted-by":"publisher","first-page":"9653","DOI":"10.3748\/wjg.v20.i29.9653","volume":"20","author":"ER Mann","year":"2014","unstructured":"Mann, E. R. & Li, X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterology: WJG 20, 9653 (2014).","journal-title":"World J. Gastroenterology: WJG"},{"key":"69848_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1126\/science.aao1503","volume":"359","author":"I Leonardi","year":"2018","unstructured":"Leonardi, I. et al. CX3CR1+, mononuclear phagocytes control immunity to intestinal fungi. Science 359, 232\u2013236 (2018).","journal-title":"Science"},{"key":"69848_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2011.01.016","volume":"34","author":"U Hadis","year":"2011","unstructured":"Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34, 237\u2013246 (2011).","journal-title":"Immunity"},{"key":"69848_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.immuni.2018.05.009","volume":"49","author":"M Kim","year":"2018","unstructured":"Kim, M. et al. Critical role for the microbiota in CX3CR1+ intestinal mononuclear phagocyte regulation of intestinal T cell responses. Immunity 49, 151\u2013163.e5 (2018).","journal-title":"Immunity"},{"key":"69848_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.immuni.2014.03.012","volume":"40","author":"E Zigmond","year":"2014","unstructured":"Zigmond, E. et al. Macrophage-restricted interleukin-10 receptor deficiency, but not il-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720\u2013733 (2014).","journal-title":"Immunity"},{"key":"69848_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11148-2","volume":"10","author":"G Desalegn","year":"2019","unstructured":"Desalegn, G. & Pabst, O. Inflammation triggers immediate rather than progressive changes in monocyte differentiation in the small intestine. Nat. Commun. 10, 1\u201314 (2019). 2019 10:1.","journal-title":"Nat. Commun."},{"key":"69848_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mi.2012.89","volume":"6","author":"CC Bain","year":"2013","unstructured":"Bain, C. C. et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6, 498\u2013510 (2013). 6:3 2012.","journal-title":"Mucosal Immunol."},{"key":"69848_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/hep.27982","volume":"62","author":"KM Schneider","year":"2015","unstructured":"Schneider, K. M. et al. CX3CR1 Is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology 62, 1405\u20131416 (2015).","journal-title":"Hepatology"},{"key":"69848_CR32","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1172\/JCI59150","volume":"121","author":"O Medina-Contreras","year":"2011","unstructured":"Medina-Contreras, O. et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest 121, 4787\u20134795 (2011).","journal-title":"J. Clin. Invest"},{"key":"69848_CR33","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4110\/in.2018.18.e5","volume":"18","author":"L Myoungsoo","year":"2018","unstructured":"Myoungsoo, L., Lee, Y., Song, J., Lee, J. & Chang, S.-Y. Tissue-specific role of CX3CR1 expressing immune cells and their relationships with human disease. Immune Netw. 18, e5 (2018).","journal-title":"Immune Netw."},{"key":"69848_CR34","doi-asserted-by":"publisher","first-page":"104346","DOI":"10.1016\/j.isci.2022.104346","volume":"25","author":"M Cavarelli","year":"2022","unstructured":"Cavarelli, M. et al. Identification of CX3CR1 + mononuclear phagocyte subsets involved in HIV-1 and SIV colorectal transmission. iScience 25, 104346 (2022).","journal-title":"iScience"},{"key":"69848_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","volume":"254","author":"M Paiardini","year":"2013","unstructured":"Paiardini, M. & M\u00fcller-Trutwin, M. HIV-associated chronic immune activation. Immunol. Rev. 254, 78 (2013).","journal-title":"Immunol. Rev."},{"key":"69848_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/COH.0b013e3283499cf6","volume":"6","author":"SE Bosinger","year":"2011","unstructured":"Bosinger, S. E., Sodora, D. L. & Silvestri, G. Generalized immune activation and innate immune responses in SIV infection. Curr. Opin. HIV AIDS 6, 411 (2011).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69848_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes, J. D. et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med 23, 1271\u20131276 (2017).","journal-title":"Nat. Med"},{"key":"69848_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/biomedicines11010159","volume":"11","author":"L Mazzuti","year":"2023","unstructured":"Mazzuti, L., Turriziani, O. & Mezzaroma, I. The many faces of immune activation in HIV-1 infection: a multifactorial interconnection. Biomedicines 11, 159 (2023).","journal-title":"Biomedicines"},{"key":"69848_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/COH.0000000000000118","volume":"10","author":"R Rajasuriar","year":"2015","unstructured":"Rajasuriar, R., Wright, E. & Lewin, S. R. Impact of antiretroviral therapy (ART) timing on chronic immune activation\/inflammation and end-organ damage. Curr. Opin. HIV AIDS 10, 35 (2015).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69848_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9734\/aji\/2025\/v8i1166","volume":"8","author":"SA Adavba","year":"2025","unstructured":"Adavba, S. A. The role of monocytes and macrophages in the pathogenesis of non-AIDS defining events: mechanisms and therapeutic implications. Asian J. Immunol. 8, 120\u2013133 (2025).","journal-title":"Asian J. Immunol."},{"key":"69848_CR41","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41385-018-0032-5","volume":"11","author":"T Hensley-McBain","year":"2018","unstructured":"Hensley-McBain, T. et al. Intestinal damage precedes mucosal immune dysfunction in SIV infection. Mucosal Immunol. 11, 1429 (2018).","journal-title":"Mucosal Immunol."},{"key":"69848_CR42","doi-asserted-by":"publisher","unstructured":"Fell, S.L. et al. Inflammatory neutrophil responses and T cell activation in ART-treated SIVmac239-infected rhesus macaques. J. Immunol. https:\/\/doi.org\/10.1093\/JIMMUN\/VKAF100 (2025).","DOI":"10.1093\/JIMMUN\/VKAF100"},{"key":"69848_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/QAD.0000000000003799","volume":"38","author":"C Tincati","year":"2024","unstructured":"Tincati, C. et al. Primary HIV Infection Features Colonic Damage and Neutrophil Inflammation yet Containment of Microbial Translocation. AIDS 38, 623\u2013632 (2024).","journal-title":"AIDS"},{"key":"69848_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1176-5","volume":"15","author":"E Cassol","year":"2015","unstructured":"Cassol, E. et al. CD14+ macrophages that accumulate in the colon of african aids patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide. BMC Infect. Dis. 15, 430 (2015).","journal-title":"BMC Infect. Dis."},{"key":"69848_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virol.2006.02.031","volume":"349","author":"F Porcheray","year":"2006","unstructured":"Porcheray, F., Samah, B., L\u00e9one, C., Dereuddre-Bosquet, N. & Gras, G. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349, 112\u2013120 (2006).","journal-title":"Virology"},{"key":"69848_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/infdis\/jit547","volume":"209","author":"K Allers","year":"2014","unstructured":"Allers, K. et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J. Infect. Dis. 209, 739\u2013748 (2014).","journal-title":"J. Infect. Dis."},{"key":"69848_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44389-3","volume":"15","author":"C Passaes","year":"2024","unstructured":"Passaes, C. et al. Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8\u2009+\u2009T-Cells. Nat. Commun. 15, 178 (2024).","journal-title":"Nat. Commun."},{"key":"69848_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye, A. A. & Picker, L. J. CD4\u2009+\u2009T-cell depletion in hiv infection: mechanisms of immunological failure. Immunol. Rev. 254, 54\u201364 (2013).","journal-title":"Immunol. Rev."},{"key":"69848_CR49","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1128\/JVI.00338-20","volume":"94","author":"Z Strongin","year":"2020","unstructured":"Strongin, Z. et al. Virologic and immunologic features of simian immunodeficiency virus control post-ART interruption in rhesus macaques. J. Virol. 94, e00338\u201320 (2020).","journal-title":"J. Virol."},{"key":"69848_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nm.3445","volume":"20","author":"MJ Buzon","year":"2014","unstructured":"Buzon, M. J. et al. HIV-1 persistence in CD4\u2009+\u2009T cells with stem cell-like properties. Nat. Med 20, 139\u2013142 (2014).","journal-title":"Nat. Med"},{"key":"69848_CR51","doi-asserted-by":"publisher","first-page":"e00377","DOI":"10.1128\/JVI.00377-19","volume":"93","author":"J Pu\u0161nik","year":"2019","unstructured":"Pu\u0161nik, J. et al. Expansion of stem cell-like CD4+ memory T cells during acute HIV-1 infection is linked to rapid disease progression. J. Virol. 93, e00377\u201319 (2019).","journal-title":"J. Virol."},{"key":"69848_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"69848_CR53","doi-asserted-by":"publisher","first-page":"e1005761","DOI":"10.1371\/journal.ppat.1005761","volume":"12","author":"R Fromentin","year":"2016","unstructured":"Fromentin, R. et al. CD4\u2009+\u2009T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. PLoS Pathog. 12, e1005761 (2016).","journal-title":"PLoS Pathog."},{"key":"69848_CR54","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.4049\/jimmunol.1303193","volume":"192","author":"EK Cartwright","year":"2014","unstructured":"Cartwright, E. K. et al. Divergent CD4\u2009+\u2009T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections.  J. Immunol. 192, 4666\u20134673 (2014).","journal-title":"J. Immunol."},{"key":"69848_CR55","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.4049\/jimmunol.1801457","volume":"202","author":"N Takahashi","year":"2019","unstructured":"Takahashi, N. et al. Shifting dynamics of intestinal macrophages during SIV infection in adult rhesus macaques. J. Immunol. 202, 2682 (2019).","journal-title":"J. Immunol."},{"key":"69848_CR56","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/eji.201545738","volume":"46","author":"ZD Swan","year":"2015","unstructured":"Swan, Z. D., Wonderlich, E. R. & Barratt-Boyes, S. M. Macrophage accumulation in gut mucosa differentiates AIDS from Chronic SIV Infection in Rhesus Macaques. Eur. J. Immunol. 46, 446 (2015).","journal-title":"Eur. J. Immunol."},{"key":"69848_CR57","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mi.2012.89","volume":"6","author":"CC Bain","year":"2013","unstructured":"Bain, C. C. et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C Hi Monocyte Precursors. Mucosal Immunol. 6, 498\u2013510 (2013).","journal-title":"Mucosal Immunol."},{"key":"69848_CR58","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.4049\/jimmunol.1400502","volume":"193","author":"MC Little","year":"2014","unstructured":"Little, M. C., Hurst, R. J. M. & Else, K. J. Dynamic changes in macrophage activation and proliferation during the development and resolution of intestinal inflammation.  J. Immunol. 193, 4684\u20134695 (2014).","journal-title":"J. Immunol."},{"key":"69848_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4049\/immunohorizons.1900038","volume":"3","author":"M Burgess","year":"2019","unstructured":"Burgess, M., Wicks, K., Gardasevic, M. & Mace, K. A. Cx3CR1 expression identifies distinct macrophage populations that contribute differentially to inflammation and repair. Immunohorizons 3, 262\u2013273 (2019).","journal-title":"Immunohorizons"},{"key":"69848_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/eji.201040965","volume":"41","author":"B Weber","year":"2011","unstructured":"Weber, B., Saurer, L., Schenk, M., Dickgreber, N. & Mueller, C. CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur. J. Immunol. 41, 773\u2013779 (2011).","journal-title":"Eur. J. Immunol."},{"key":"69848_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.imlet.2021.02.001","volume":"232","author":"J Li","year":"2021","unstructured":"Li, J. et al. Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease. Immunol. Lett. 232, 39\u201344 (2021).","journal-title":"Immunol. Lett."},{"key":"69848_CR62","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni.2967","volume":"15","author":"CC Bain","year":"2014","unstructured":"Bain, C. C. et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 15, 929\u2013937 (2014).","journal-title":"Nat. Immunol."},{"key":"69848_CR63","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/eji.201141714","volume":"41","author":"C Bain","year":"2011","unstructured":"Bain, C. & Mowat, A. Intestinal macrophages - specialised adaptation to a unique environment. Eur. J. Immunol. 41, 2494\u20132498 (2011).","journal-title":"Eur. J. Immunol."},{"key":"69848_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1176-5","volume":"15","author":"E Cassol","year":"2015","unstructured":"Cassol, E. et al. CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide. BMC Infect. Dis. 15, 430 (2015).","journal-title":"BMC Infect. Dis."},{"key":"69848_CR65","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/eji.201646904","volume":"47","author":"ZD Swan","year":"2017","unstructured":"Swan, Z. D., Bouwer, A. L., Wonderlich, E. R. & Barratt-Boyes, S. M. Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques. Eur. J. Immunol. 47, 1925\u20131935 (2017).","journal-title":"Eur. J. Immunol."},{"key":"69848_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000842","volume":"6","author":"TH Burdo","year":"2010","unstructured":"Burdo, T. H. et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog. 6, 1\u201313 (2010).","journal-title":"PLoS Pathog."},{"key":"69848_CR67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11809","volume":"494","author":"GE Diehl","year":"2013","unstructured":"Diehl, G. E. et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX 3 CR1 Hi cells. Nature 494, 116\u2013120 (2013).","journal-title":"Nature"},{"key":"69848_CR68","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20140678","volume":"211","author":"RS Longman","year":"2014","unstructured":"Longman, R. S. et al. CX\u2083CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med 211, 1571\u20131583 (2014).","journal-title":"J. Exp. Med"},{"key":"69848_CR69","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/19490976.2018.1559683","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim, M., Hill, A. A., Wu, W.-J. & Diehl, G. E. Intestinal microbes direct CX 3 CR1 + cells to balance intestinal immunity. Gut Microbes 10, 540\u2013546 (2019).","journal-title":"Gut Microbes"},{"key":"69848_CR70","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/mi.2012.38","volume":"5","author":"NR Klatt","year":"2012","unstructured":"Klatt, N. R. et al. Loss of Mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5, 646\u2013657 (2012).","journal-title":"Mucosal Immunol."},{"key":"69848_CR71","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood-2008-05-159301","volume":"112","author":"JM Brenchley","year":"2008","unstructured":"Brenchley, J. M. et al. Differential Th17 CD4 T-Cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112, 2826\u20132835 (2008).","journal-title":"Blood"},{"key":"69848_CR72","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/mi.2008.14","volume":"1","author":"V Cecchinato","year":"2008","unstructured":"Cecchinato, V. et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 1, 279\u2013288 (2008).","journal-title":"Mucosal Immunol."},{"key":"69848_CR73","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fimmu.2016.00228","volume":"7","author":"P Pandiyan","year":"2016","unstructured":"Pandiyan, P. et al. Mucosal regulatory T cells and T helper 17 cells in HIV-associated immune activation. Front Immunol. 7, 228 (2016).","journal-title":"Front Immunol."},{"key":"69848_CR74","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.1128\/JVI.00841-07","volume":"81","author":"AJ Chase","year":"2007","unstructured":"Chase, A. J. et al. Severe depletion of CD4\u2009+\u2009CD25 + regulatory t cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J. Virol. 81, 12748\u201312757 (2007).","journal-title":"J. Virol."},{"key":"69848_CR75","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.4049\/jimmunol.180.8.5530","volume":"180","author":"S Qin","year":"2008","unstructured":"Qin, S. et al. Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection.  J. Immunol. 180, 5530\u20135536 (2008).","journal-title":"J. Immunol."},{"key":"69848_CR76","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1128\/JVI.01715-09","volume":"84","author":"K Allers","year":"2010","unstructured":"Allers, K. et al. Gut mucosal FOXP3 + regulatory CD4\u2009+\u2009T cells and nonregulatory CD4\u2009+\u2009T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques. J. Virol. 84, 3259\u20133269 (2010).","journal-title":"J. Virol."},{"key":"69848_CR77","doi-asserted-by":"publisher","first-page":"e161111","DOI":"10.1172\/jci.insight.161111","volume":"8","author":"C Apetrei","year":"2023","unstructured":"Apetrei, C. et al. T cell activation is insufficient to drive SIV disease progression. JCI Insight 8, e161111 (2023).","journal-title":"JCI Insight"},{"key":"69848_CR78","doi-asserted-by":"publisher","first-page":"e1981","DOI":"10.1002\/rmv.1981","volume":"28","author":"M Garc\u00eda","year":"2018","unstructured":"Garc\u00eda, M., Buz\u00f3n, M. J., Benito, J. M. & Rall\u00f3n, N. Peering into the HIV reservoir. Rev. Med Virol. 28, e1981 (2018).","journal-title":"Rev. Med Virol."},{"key":"69848_CR79","doi-asserted-by":"publisher","first-page":"781356","DOI":"10.3389\/fimmu.2022.781356","volume":"13","author":"J Lemaitre","year":"2022","unstructured":"Lemaitre, J. et al. Expansion of immature neutrophils during siv infection is associated with their capacity to modulate T-cell function. Front Immunol. 13, 781356 (2022).","journal-title":"Front Immunol."},{"key":"69848_CR80","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1172\/JCI99420","volume":"128","author":"R Sivanandham","year":"2018","unstructured":"Sivanandham, R. et al. Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates. J. Clin. Investig. 128, 5178\u20135183 (2018).","journal-title":"J. Clin. Investig."},{"key":"69848_CR81","doi-asserted-by":"publisher","first-page":"e1007672","DOI":"10.1371\/journal.ppat.1007672","volume":"15","author":"T Hensley-McBain","year":"2019","unstructured":"Hensley-McBain, T. et al. Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection. PLoS Pathog. 15, e1007672 (2019).","journal-title":"PLoS Pathog."},{"key":"69848_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11904-018-0370-7","volume":"15","author":"T Hensley-McBain","year":"2018","unstructured":"Hensley-McBain, T. & Klatt, N. R. The dual role of neutrophils in HIV infection. Curr. HIV\/AIDS Rep. 15, 1 (2018).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"69848_CR83","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1097\/MS9.0000000000003474","volume":"87","author":"EI Obeagu","year":"2025","unstructured":"Obeagu, E. I. Neutrophils in HIV pathogenesis: dual roles, clinical implications, and therapeutic frontiers. Ann. Med. Surg. 87, 5578\u20135587 (2025).","journal-title":"Ann. Med. Surg."},{"key":"69848_CR84","doi-asserted-by":"publisher","first-page":"e2218960120","DOI":"10.1073\/pnas.2218960120","volume":"120","author":"B Etemad","year":"2023","unstructured":"Etemad, B. et al. HIV post-treatment controllers have distinct immunological and virological features. Proc. Natl. Acad. Sci. USA 120, e2218960120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69848_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56116-1","volume":"16","author":"JD Gunst","year":"2025","unstructured":"Gunst, J. D. et al. Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies. Nat. Commun. 16, 906 (2025).","journal-title":"Nat. Commun."},{"key":"69848_CR86","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cell.2021.11.032","volume":"185","author":"J Xue","year":"2022","unstructured":"Xue, J. et al. Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide. Cell 185, 131\u2013144.e18 (2022).","journal-title":"Cell"},{"key":"69848_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07881-9","volume":"9","author":"JB Whitney","year":"2018","unstructured":"Whitney, J. B. et al. Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy. Nat. Commun. 9, 5429 (2018).","journal-title":"Nat. Commun."},{"key":"69848_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature13594","volume":"512","author":"JB Whitney","year":"2014","unstructured":"Whitney, J. B. et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512, 74\u201377 (2014).","journal-title":"Nature"},{"key":"69848_CR89","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/COH.0000000000000898","volume":"20","author":"FS Mesquita","year":"2025","unstructured":"Mesquita, F. S., Li, Y. & Li, J. Z. Viral and immune predictors of HIV posttreatment control. Curr. Opin. HIV AIDS 20, 54\u201360 (2025).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69848_CR90","doi-asserted-by":"publisher","unstructured":"Hua, S. et al. Intestinal immunological events of acute and resolved SARS-CoV-2 infection in non-human primates. Mucosal Immunol. https:\/\/doi.org\/10.1016\/J.MUCIMM.2023.10.001 (2023).","DOI":"10.1016\/J.MUCIMM.2023.10.001"},{"key":"69848_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/viro.1997.9026","volume":"243","author":"O Neildez","year":"1998","unstructured":"Neildez, O. et al. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus. Virology 243, 12\u201320 (1998).","journal-title":"Virology"},{"key":"69848_CR92","doi-asserted-by":"publisher","first-page":"e1005153","DOI":"10.1371\/journal.ppat.1005153","volume":"11","author":"A Damouche","year":"2015","unstructured":"Damouche, A. et al. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog. 11, e1005153 (2015).","journal-title":"PLoS Pathog."},{"key":"69848_CR93","doi-asserted-by":"publisher","first-page":"108174","DOI":"10.1016\/j.celrep.2020.108174","volume":"32","author":"C Passaes","year":"2020","unstructured":"Passaes, C. et al. Optimal maturation of the SIV-Specific CD8\u2009+\u2009T cell response after primary infection is associated with natural control of SIV: ANRS SIC study. Cell Rep. 32, 108174 (2020).","journal-title":"Cell Rep."},{"key":"69848_CR94","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00251-010-0504-6","volume":"63","author":"A Aarnink","year":"2011","unstructured":"Aarnink, A. et al. Influence of the MHC genotype on the progression of experimental SIV infection in the mauritian cynomolgus macaque. Immunogenetics 63, 267\u2013274 (2011).","journal-title":"Immunogenetics"},{"key":"69848_CR95","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00251-009-0369-8","volume":"61","author":"ET Mee","year":"2009","unstructured":"Mee, E. T. et al. MHC haplotype H6 Is associated with sustained control of SIVmac251 infection in mauritian cynomolgus macaques. Immunogenetics 61, 327\u2013339 (2009).","journal-title":"Immunogenetics"},{"key":"69848_CR96","doi-asserted-by":"publisher","first-page":"101815","DOI":"10.1016\/j.xpro.2022.101815","volume":"3","author":"K Benmeziane","year":"2022","unstructured":"Benmeziane, K. et al. Isolation and phenotypic characterization of human and nonhuman primate intestinal lamina propria mononuclear cells. STAR Protoc. 3, 101815 (2022).","journal-title":"STAR Protoc."},{"key":"69848_CR97","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/08892220050117014","volume":"16","author":"R Hofmann-Lehmann","year":"2000","unstructured":"Hofmann-Lehmann, R. et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum. Retroviruses 16, 1247\u20131257 (2000).","journal-title":"AIDS Res Hum. Retroviruses"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69848-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69848-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69848-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:19:33Z","timestamp":1774984773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69848-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69848"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69848-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S.C. has received speaker fees from M.S.D., ViiV Healthcare, Gilead, and Janssen. V.A.F. has received grants (to her institution) from ViiV Healthcare and honoraria and travel grants from ViiV Healthcare and Gilead Sciences for participation in educational programs and conferences. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3111"}}